Everpar Advisors LLC Sells 177 Shares of CME Group Inc. (NASDAQ:CME)

Everpar Advisors LLC reduced its stake in CME Group Inc. (NASDAQ:CMEFree Report) by 9.9% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,609 shares of the financial services provider’s stock after selling 177 shares during the period. Everpar Advisors LLC’s holdings in CME Group were worth $427,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in the stock. SeaCrest Wealth Management LLC boosted its position in shares of CME Group by 3.0% in the 1st quarter. SeaCrest Wealth Management LLC now owns 1,379 shares of the financial services provider’s stock worth $366,000 after purchasing an additional 40 shares during the last quarter. New Age Alpha Advisors LLC lifted its holdings in CME Group by 50.0% during the fourth quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider’s stock worth $30,000 after acquiring an additional 43 shares in the last quarter. Avidian Wealth Enterprises LLC lifted its holdings in CME Group by 2.6% during the fourth quarter. Avidian Wealth Enterprises LLC now owns 1,769 shares of the financial services provider’s stock worth $411,000 after acquiring an additional 45 shares in the last quarter. Venturi Wealth Management LLC lifted its holdings in CME Group by 12.1% during the fourth quarter. Venturi Wealth Management LLC now owns 437 shares of the financial services provider’s stock worth $101,000 after acquiring an additional 47 shares in the last quarter. Finally, Wealthcare Advisory Partners LLC lifted its holdings in CME Group by 3.6% during the first quarter. Wealthcare Advisory Partners LLC now owns 1,342 shares of the financial services provider’s stock worth $356,000 after acquiring an additional 47 shares in the last quarter. 87.75% of the stock is currently owned by institutional investors.

CME Group Stock Performance

CME opened at $269.50 on Friday. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.02. The business’s 50-day moving average price is $272.73 and its two-hundred day moving average price is $254.28. The company has a market capitalization of $97.12 billion, a price-to-earnings ratio of 27.87, a P/E/G ratio of 6.76 and a beta of 0.45. CME Group Inc. has a 1 year low of $190.70 and a 1 year high of $290.79.

CME Group (NASDAQ:CMEGet Free Report) last released its earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.61 by $0.19. The business had revenue of $1.64 billion for the quarter, compared to the consensus estimate of $1.56 billion. CME Group had a return on equity of 13.62% and a net margin of 57.52%. CME Group’s quarterly revenue was up 10.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.50 earnings per share. Equities analysts expect that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Monday, June 9th will be given a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a yield of 1.86%. The ex-dividend date of this dividend is Monday, June 9th. CME Group’s dividend payout ratio (DPR) is presently 50.30%.

Wall Street Analysts Forecast Growth

CME has been the topic of several recent analyst reports. Piper Sandler lifted their target price on CME Group from $275.00 to $283.00 and gave the stock an “overweight” rating in a report on Tuesday, April 8th. UBS Group lifted their target price on CME Group from $290.00 to $305.00 and gave the stock a “buy” rating in a report on Friday, April 25th. Keefe, Bruyette & Woods lifted their target price on CME Group from $265.00 to $273.00 and gave the stock a “market perform” rating in a report on Thursday, April 24th. Bank of America lifted their target price on CME Group from $200.00 to $219.00 and gave the stock an “underperform” rating in a report on Wednesday, April 2nd. Finally, Erste Group Bank lowered CME Group from a “strong-buy” rating to a “hold” rating in a report on Saturday, May 24th. Three research analysts have rated the stock with a sell rating, eight have issued a hold rating and five have assigned a buy rating to the company’s stock. Based on data from MarketBeat, CME Group presently has a consensus rating of “Hold” and a consensus price target of $258.20.

Read Our Latest Research Report on CME

Insiders Place Their Bets

In other news, Director Larry G. Gerdes sold 2,000 shares of the business’s stock in a transaction that occurred on Thursday, April 24th. The stock was sold at an average price of $264.10, for a total transaction of $528,200.00. Following the completion of the sale, the director now owns 38,651 shares in the company, valued at $10,207,729.10. The trade was a 4.92% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Derek Sammann sold 4,650 shares of the business’s stock in a transaction that occurred on Monday, May 5th. The shares were sold at an average price of $280.61, for a total value of $1,304,836.50. Following the completion of the sale, the insider now owns 8,336 shares of the company’s stock, valued at approximately $2,339,164.96. This trade represents a 35.81% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 13,400 shares of company stock valued at $3,680,610 over the last 90 days. 0.30% of the stock is currently owned by insiders.

About CME Group

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Featured Stories

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.